Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone in mice bearing S180 tumor

Journal of Experimental Therapeutics and Oncology

Volumn 7, Issue 2, 2008, Pages 113-121

  Bezerra, Daniel Pereira ^a   Alves, Ana Paula Negreiros Nunes ^a   De Alencar, Nylane Maria Nunes ^a   Mesquita, Rodney De Oliveira ^a   Lima, Michael Will ^a   Pessoa, Cláudia ^a   De Moraes, Manoel Odorico ^a   Lopes, José Norberto Callegari ^b   Lopes, Norberto Peporine ^b   Costa Lotufo, Letícia Veras ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

2 butanoylamine 1,4 naphthoquinone; 2 propanoylamine 1,4 naphthoquinone; Antitumor activity; Naphthoquinones; Sarcoma 180; Toxicity

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 BUTANOYLAMINE 1,4 NAPHTHOQUINONE; 2 PROPANOYLAMINE 1,4 NAPTHOQUINONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD ANALYSIS; CANCER INHIBITION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; UREA BLOOD LEVEL;

ALANINE TRANSAMINASE; ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; BLOOD CELL COUNT; BODY WEIGHT; FEMALE; KIDNEY; MICE; NAPHTHOQUINONES; NEOPLASM TRANSPLANTATION; ORGAN SIZE; SARCOMA 180; UREA;

EID: 49549099772     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. O'Brien P. Molecular mechanisms of quinone cytotoxicity. J Chem Biol Interact 80:1-41, 1991.
2. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol Appl Pharmacol 112:2-16, 1992.
3. Owton WM. The synthesis of quinones. J Chem Soc, Perkin Trans. 1999;1:2409-2420.
4. Thomson RH. In Total synthesis of natural products.; ApSimon J ed. New York: John Wiley. 8. 1992.
5. Vessecchi R, Nascimento, PGBD, Lopes JNC, Lopes NP. Fragmentation studies of synthetic 2-acylamino-1,4-naphthoquinones by electrospray ionization mass spectrometry. J Mass Spectromet 41:1219-1225, 2006.
6. Foye MO. Cancer Chemotherapeutic Agents. American Chemical Society. Washington, D.C. 203. 1993.
7. Leopold WR, Shillis JL, Menus AE, Nelson JM, Roberts BJ, Jackson RC. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues. Cancer Res 44:1928-1932, 1984.
8. Scheithauer W, Von-Hoff DD, Clark GM, Shillis JL, Elslager EF. In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay. Eur J Cancer Clin Oncol 22:921-926, 1986.
9. Lopes JNC, Johnson AW, Grove JF, Bulhoes MS. Síntese de derivados da 2-Amino-1,4-naftoquinona e avaliação de suas atividades larvicida e moluscocida. Ciênc Cult 29:1145-1149, 1977.
10. Bezerra DP, Castro FO, Alves APNN, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV. In vivo growth-inhibition of sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. Brat J Med Bio Res 39:801-807, 2006.
11. Lima OG, Maciel GM, Oliveira LL, Lacerda AL, Moreira LC, Martins DG. Substâncias antimicrobianas de plantas superiores. Comunicaçã o XXXVII. Atividade antimicrobiana e antineoplásica de Juglona (5-hidroxi-1,4-naftoquinona), Lapachol (2-hidroxi-3-(3-metil-2-butenil)-1,4- naftoquinona) e Plumbagina (2-metil-5-hidroxi-1,4-naftoquinona) e Lawsona (2-hidroxi-1,4-naftoquinona). Rev Inst Antib 12:3-12, 1972.
12. Docampo R, Souza W, Cruz FS, Roitman I, Cover B, Gutteridge WE. Ultrastructural alterations and peroxide formation induced by naphtoquinonesin different stages of Trypanosoma cruzi. Parasitol Res 57:189-198, 1978.
13. Santana CF, Lima OGD, Albuquerque IL, Lacerda AL, Martins DG. Observações sobre as propriedades antitumorais e toxicológicas do extrato do líber e de alguns componentes do cerne do pau d́arco (Tabebuia avellanedae). Rev Inst Antib 8:89-94, 1968.
14. Oliveira MM, Linardi MCF, Sampaio MRP. Effects of quinone derivatives on an experimental tumor. J Pharmaceut Scienc 67:562-563, 1978.
15. Kim BH, Yoo J, Park SH, Jung JK, Cho H, Chung Y. Synthesis and evaluation of antitumor activity of novel 1,4-naphthoquinone derivatives (IV). Arch Pharm Res 29:123-30, 2006.
16. Lown JW, Sim SK, Majumdar KC, Chang RY. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. Biochem Biophys Res Commun 76:705-710, 1977.
17. Tewey KM, Chen GL, Nelson EM, Liu LF. Intercalative antitumor drugs interfere with the breakagereunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:9182-9187, 1984.
18. Hertzberg RP, Dervan PB: Cleavage of DNA with methidiumpropyl-EDTA- iron(II): reaction conditions and product analyses. Biochemistry 23:3934-3945, 1994.
19. Silverman RB. The organic chemistry of drug design and drug action. New York: Academic Press. 255-258. 1992.
20. Morrison RK, Brown DE, Oleson JJ, Cooney DA. Oral toxicology studies with Lapachol. Toxicol Appl Pharmacol 17:1-11, 1970.
21. Scheuer PJ, Lefkowitch JH. Drugs and Toxins. In PJ Scheuer & JH Lefkowitch eds. Liver biopsy interpretation. London: WB Saunders. 134-150. 2000.
22. Kummar V, Abbas A, Fausto N: Robbins & Cotran pathology basis of disease. China: WB Saunders. 2004.
23. McGee JOD, Isaacson PA, Wright NA. Oxford textbook of pathology. Pathology of systems. New York: Oxford University Press. 1992.
24. Curran R C. Color atlas of histopathology. New York: Oxford University Press. 1990.
25. Olsen S, Solez K. Acute tubular necrosis and toxic renal injury. In CC Tisher & BM Brenner eds. Renal pathology: With clinical and functional correlations. Philadelphia: J.B. Lippincott Company. 769-809. 1994.
26. th edition 452. 1980.
27. Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Nakajima N. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 47:11-4, 2001.
28. Okawa Y, Murata Y, Kobayashi M, Suzuki ME, Suzuki S. Argumentation of host resistance to Candida albicans infection in ascite tumor-bearing mice. Microbiol Immunol 36:517-521, 1992.